Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Kidney Transplant
Phase 4
Withdrawn
- Conditions
- Kidney FailureKidney DiseasesHepatitis C
- Interventions
- Drug: glecaprevir/pibrentasvir tablets
- First Posted Date
- 2018-08-09
- Last Posted Date
- 2019-06-03
- Lead Sponsor
- Raymond T. Chung, MD
- Registration Number
- NCT03623568
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Preemptive Zepatier Treatment in Donor HCV Positive to Recipient HCV Negative Cardiac Transplant
Phase 4
Withdrawn
- Conditions
- Cardiac Transplant DisorderHepatitis C
- Interventions
- Drug: Combindation treatment with Grazoprevir and Elbasvir fixed dose combination tablet, with or without ribavirin
- First Posted Date
- 2017-01-20
- Last Posted Date
- 2018-12-20
- Lead Sponsor
- Raymond T. Chung, MD
- Registration Number
- NCT03026023
- Locations
- 🇺🇸
Masschusetts General Hospital, Boston, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath